Association between the soluble epoxide hydrolase gene and preeclampsia

被引:8
作者
Sari, Ismail [1 ]
Pinarbasi, Hatice [2 ]
Pinarbasi, Ergun [3 ]
Yildiz, Caglar [4 ]
机构
[1] Nigde Omer Halisdemir Univ, Sch Med, Dept Med Biochem, Nigde, Turkey
[2] Cumhuriyet Univ, Sch Med, Dept Biochem, TR-58140 Sivas, Turkey
[3] Cumhuriyet Univ, Sch Med, Dept Med Biol, Sivas, Turkey
[4] Cumhuriyet Univ, Sch Med, Dept Gynecol & Obstet, Sivas, Turkey
关键词
Soluble epoxide hydrolase; genetic polymorphism; epoxyeicosatrienoic acid; methylation; EPOXYEICOSATRIENOIC ACIDS; BLOOD-PRESSURE; CYTOCHROME-P450; EPOXYGENASES; RISK; HYPERTENSION; METHYLATION; ATHEROSCLEROSIS; EXPRESSION; PREGNANCY; DISEASE;
D O I
10.1080/10641955.2017.1388390
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective: In this study the association between K55R polymorphism, methylation level of the EPHX2 promoter region, and PE was investigated in 520 individuals including 260 PE patients and 260 healthy pregnant women.Methods: K55R polymorphism and methylation level of the EPHX2 promoter were determined by the real-time PCR using double-dye hydrolysis probes and methylation-sensitive high-resolution melting analysis, respectively.Results: The presence of the K55R polymorphism was significantly higher in cases (28.1%) than controls (17.3%), and was associated with increased risk of PE (OR: 1.86; 95% CI: 1.09-2.63). Methylation levels of the EPHX2 promoter region in cases were significantly lower than controls. A 2.83 times increased PE risk was observed in pregnant women with EPHX2 promoter methylation levels of <25% (OR: 2.83; 95% CI: 1.15-6.91).Conclusion: In conclusion, hypomethylation of the promoter region of EPHX2 and K55R polymorphism were associated with significant increased risk of PE. sEH enzyme may play a role in the pathogenesis of PE by contributing to reduction of the vasodilatator, anti-hypertensive, and anti-inflammatory effects of EETs by rapid degradation of these molecules.
引用
收藏
页码:315 / 325
页数:11
相关论文
共 70 条
[41]  
Oltman CL, 1998, CIRC RES, V83, P932
[42]   Epoxyeicosatrienoic acids and cardioprotection: The road to translation [J].
Oni-Orisan, Akinyemi ;
Alsaleh, Nasser ;
Lee, Craig R. ;
Seubert, John M. .
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2014, 74 :199-208
[43]   CYTOSOLIC EPOXIDE HYDROLASE IN HUMANS - DEVELOPMENT AND TISSUE DISTRIBUTION [J].
PACIFICI, GM ;
TEMELLINI, A ;
GIULIANI, L ;
RANE, A ;
THOMAS, H ;
OESCH, F .
ARCHIVES OF TOXICOLOGY, 1988, 62 (04) :254-257
[44]   Polymorphisms in human soluble epoxide hydrolase [J].
Przybyla-Zawislak, BD ;
Srivastava, PK ;
Vázquez-Matías, J ;
Mohrenweiser, HW ;
Maxwell, JE ;
Hammock, BD ;
Bradbury, JA ;
Enayetallah, AE ;
Zeldin, DC ;
Grant, DF .
MOLECULAR PHARMACOLOGY, 2003, 64 (02) :482-490
[45]   Soluble Epoxide Hydrolase Inhibitors and Heart Failure [J].
Qiu, Hong ;
Li, Ning ;
Liu, Jun-Yan ;
Harris, Todd R. ;
Hammock, Bruce D. ;
Chiamvimonvat, Nipavan .
CARDIOVASCULAR THERAPEUTICS, 2011, 29 (02) :99-111
[46]   Latest advances in understanding preeclampsia [J].
Redman, CW ;
Sargent, IL .
SCIENCE, 2005, 308 (5728) :1592-1594
[47]   Soluble Epoxide Hydrolase Deficiency Attenuates Neointima Formation in the Femoral Cuff Model of Hyperlipidemic Mice [J].
Revermann, Marc ;
Schloss, Manuel ;
Barbosa-Sicard, Eduardo ;
Mieth, Anja ;
Liebner, Stefan ;
Morisseau, Christophe ;
Geisslinger, Gerd ;
Schermuly, Ralph T. ;
Fleming, Ingrid ;
Hammock, Bruce D. ;
Brandes, Ralf P. .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2010, 30 (05) :909-U53
[48]  
Roberts JM, 2013, OBSTET GYNECOL, V122, P1122, DOI 10.1097/01.AOG.0000437382.03963.88
[49]   Role of placentally produced inflammatory and regulatory cytokines in pregnancy and the etiology of preeclampsia [J].
Rusterholz, Corinne ;
Hahn, Sinuhe ;
Holzgreve, Wolfagang .
SEMINARS IN IMMUNOPATHOLOGY, 2007, 29 (02) :151-162
[50]   EPIDEMIOLOGY OF PREECLAMPSIA AND ECLAMPSIA IN THE UNITED-STATES, 1979-1986 [J].
SAFTLAS, AF ;
OLSON, DR ;
FRANKS, AL ;
ATRASH, HK ;
POKRAS, R .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1990, 163 (02) :460-465